EP Patent

EP3542786A1 — Progesterone intravaginal devices

Assigned to ITF Research Pharma SL · Expires 2019-09-25 · 7y expired

What this patent protects

The invention relates to intravaginal devices, preferably rings, comprising progesterone in a particular polymorphic purity, methods for making such decvices and therapeutic uses of said devices. In particular, the intravaginal devices comprise a high amount of progesterone polym…

USPTO Abstract

The invention relates to intravaginal devices, preferably rings, comprising progesterone in a particular polymorphic purity, methods for making such decvices and therapeutic uses of said devices. In particular, the intravaginal devices comprise a high amount of progesterone polymorph I and are useful in the treatment of infertility in a female subject.

Drugs covered by this patent

Patent Metadata

Patent number
EP3542786A1
Jurisdiction
EP
Classification
—
Expires
2019-09-25
Drug substance claim
No
Drug product claim
No
Assignee
ITF Research Pharma SL
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.